
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Check out the new and improved iPad app for Contemporary Pediatrics! The app features tons of interactive content and a better way to view our magazine. All issues are completely free!
Click here to download the app.






